2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶作为一种新型抗乙型肝炎病毒和爱泼斯坦-巴尔病毒的抗病毒药物的用途。
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.
作者信息
Chu C K, Ma T, Shanmuganathan K, Wang C, Xiang Y, Pai S B, Yao G Q, Sommadossi J P, Cheng Y C
机构信息
Department of Medicinal Chemistry, College of Pharmacy, University of Georgia, Athens 30602, USA.
出版信息
Antimicrob Agents Chemother. 1995 Apr;39(4):979-81. doi: 10.1128/AAC.39.4.979.
Abstract
A novel anti-hepatitis B virus (anti-HBV) agent, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil (L-FMAU), was synthesized and found to be a potent anti-HBV and anti-Epstein-Barr virus agent. Its in vitro potency was evaluated in 2.2.15 and H1 cells for anti-HBV and anti-Epstein-Barr virus activities, respectively. In vitro cytotoxicity in MT2, CEM, 2.2.15, and H1 cells was also assessed, and the results indicated high antiviral selectivities of L-FMAU in these cells.
摘要
一种新型抗乙型肝炎病毒（抗-HBV）药物2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶（L-FMAU）被合成出来，并且发现它是一种有效的抗HBV和抗爱泼斯坦-巴尔病毒药物。分别在2.2.15细胞和H1细胞中评估了其体外抗HBV和抗爱泼斯坦-巴尔病毒活性的效力。还评估了L-FMAU在MT2、CEM、2.2.15和H1细胞中的体外细胞毒性，结果表明L-FMAU在这些细胞中具有高抗病毒选择性。
相似文献
1
Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶作为一种新型抗乙型肝炎病毒和爱泼斯坦-巴尔病毒的抗病毒药物的用途。
Antimicrob Agents Chemother. 1995 Apr;39(4):979-81. doi: 10.1128/AAC.39.4.979.
2
Inhibition of hepatitis B virus by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyl uracil.新型L-核苷2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶对乙型肝炎病毒的抑制作用
Antimicrob Agents Chemother. 1996 Feb;40(2):380-6. doi: 10.1128/AAC.40.2.380.
3
Preclinical investigation of L-FMAU as an anti-hepatitis B virus agent.L-FMAU作为抗乙型肝炎病毒药物的临床前研究。
Antivir Ther. 1998;3(Suppl 3):113-21.
4
Inhibition of Epstein-Barr virus replication by a novel L-nucleoside, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.新型L-核苷2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶对爱泼斯坦-巴尔病毒复制的抑制作用
Biochem Pharmacol. 1996 Apr 12;51(7):941-7. doi: 10.1016/0006-2952(96)00049-4.
5
Synthesis and anti-hepatitis B virus activity of 9-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl) purine nucleosides.
J Med Chem. 1997 Aug 15;40(17):2750-4. doi: 10.1021/jm970233+.
6
In vitro susceptibilities of wild-type or drug-resistant hepatitis B virus to (-)-beta-D-2,6-diaminopurine dioxolane and 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil.野生型或耐药乙型肝炎病毒对（-）-β-D-2,6-二氨基嘌呤二氧戊环和2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶的体外敏感性。
Antimicrob Agents Chemother. 2001 Sep;45(9):2495-501. doi: 10.1128/AAC.45.9.2495-2501.2001.
7
Structure--activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents.1-(2-脱氧-2-氟-β-L-阿拉伯呋喃糖基)嘧啶核苷作为抗乙型肝炎病毒药物的构效关系
J Med Chem. 1996 Jul 5;39(14):2835-43. doi: 10.1021/jm960098l.
8
Understanding the unique mechanism of L-FMAU (clevudine) against hepatitis B virus: molecular dynamics studies.了解L-FMAU（克来夫定）抗乙型肝炎病毒的独特机制：分子动力学研究
Bioorg Med Chem Lett. 2002 Dec 2;12(23):3459-62. doi: 10.1016/s0960-894x(02)00747-3.
9
Potential use of antiviral L(-)nucleoside analogues for the prevention or treatment of viral associated cancers.抗病毒L(-)核苷类似物在预防或治疗病毒相关癌症中的潜在应用。
Cancer Lett. 2001 Jan;162 Suppl:S33-S37. doi: 10.1016/s0304-3835(00)00650-9.
10
Unique metabolism of a novel antiviral L-nucleoside analog, 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil: a substrate for both thymidine kinase and deoxycytidine kinase.新型抗病毒L-核苷类似物2'-氟-5-甲基-β-L-阿拉伯呋喃糖基尿嘧啶的独特代谢：胸苷激酶和脱氧胞苷激酶的底物
Antimicrob Agents Chemother. 1998 Apr;42(4):833-9. doi: 10.1128/AAC.42.4.833.
引用本文的文献
1
2'-Fluorinated nucleoside chemistry for new drug discovery: achievements and prospects.用于新药研发的2'-氟代核苷化学：成就与展望
Natl Sci Rev. 2024 Oct 1;11(10):nwae331. doi: 10.1093/nsr/nwae331. eCollection 2024 Oct.
2
Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties.氟代核苷/核苷酸的合成及其抗病毒性质。
Molecules. 2024 May 19;29(10):2390. doi: 10.3390/molecules29102390.
3
Inhibition of SARS-CoV-2 infection in human airway epithelium with a xeno-nucleic acid aptamer.用异源核酸适体抑制人呼吸道上皮细胞中的 SARS-CoV-2 感染。
Respir Res. 2023 Nov 7;24(1):272. doi: 10.1186/s12931-023-02590-4.
4
Active site polymerase inhibitor nucleotides (ASPINs): Potential agents for chronic HBV cure regimens.活性位点聚合酶抑制剂核苷酸（ASPINs）：慢性乙型肝炎治愈方案的潜在药物。
Antivir Chem Chemother. 2022 Jan-Dec;30:20402066221138705. doi: 10.1177/20402066221138705.
5
ATI-2173, a Novel Liver-Targeted Non-Chain-Terminating Nucleotide for Hepatitis B Virus Cure Regimens.ATI-2173，一种新型肝靶向非链终止核苷酸，用于乙型肝炎病毒治疗方案。
Antimicrob Agents Chemother. 2020 Aug 20;64(9). doi: 10.1128/AAC.00836-20.
6
Dual Mechanisms of Action of Self-Delivering, Anti-HIV-1 FANA Oligonucleotides as a Potential New Approach to HIV Therapy.自我递送抗HIV-1 FANA寡核苷酸的双重作用机制：一种潜在的HIV治疗新方法
Mol Ther Nucleic Acids. 2019 Sep 6;17:615-625. doi: 10.1016/j.omtn.2019.07.001. Epub 2019 Jul 11.
7
The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffold.核苷类似物抗病毒药物的演进：化学家与非化学家的综述。第 1 部分：核苷骨架的早期结构修饰。
Antiviral Res. 2018 Jun;154:66-86. doi: 10.1016/j.antiviral.2018.04.004. Epub 2018 Apr 10.
8
Hepatitis B virus reverse transcriptase - Target of current antiviral therapy and future drug development.乙型肝炎病毒逆转录酶——当前抗病毒治疗的靶点与未来药物研发方向
Antiviral Res. 2015 Nov;123:132-7. doi: 10.1016/j.antiviral.2015.09.011. Epub 2015 Sep 25.
9
A randomized, open-label study comparing low-dose clevudine plus adefovir combination therapy with clevudine monotherapy in naïve chronic hepatitis B patients.一项在初治慢性乙型肝炎患者中比较低剂量克来夫定联合阿德福韦与克来夫定单药治疗的随机、开放标签研究。
Hepatol Int. 2014 May 25;8(3):375-81. doi: 10.1007/s12072-014-9537-5. eCollection 2014 Jul.
10
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.β-l-1-[5-(E-2-溴乙烯基)-2-(羟甲基)-1,3-(二氧戊环-4-基)]尿嘧啶（l-BHDU）可在SCID-Hu小鼠模型中阻止水痘带状疱疹病毒复制，且不干扰5-氟尿嘧啶的分解代谢。
Antiviral Res. 2014 Oct;110:10-9. doi: 10.1016/j.antiviral.2014.07.007. Epub 2014 Jul 19.
本文引用的文献
1
L-beta-(2S,4S)- and L-alpha-(2S,4R)-dioxolanyl nucleosides as potential anti-HIV agents: asymmetric synthesis and structure-activity relationships.
J Med Chem. 1993 Mar 5;36(5):519-28. doi: 10.1021/jm00057a001.
2
Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents.β-L-(2R,5S)-和α-L-(2R,5R)-1,3-氧硫杂环戊烷嘧啶核苷及嘌呤核苷作为潜在抗HIV药物的不对称合成与生物学评价
J Med Chem. 1993 Jan 22;36(2):181-95. doi: 10.1021/jm00054a001.
3
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.硫代磷酸酯寡脱氧核苷酸对爱泼斯坦-巴尔病毒的强效抑制作用，无序列特异性。
Antimicrob Agents Chemother. 1993 Jul;37(7):1420-5. doi: 10.1128/AAC.37.7.1420.
4
Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).2',3'-二脱氧-L-嘧啶核苷作为抗人类免疫缺陷病毒（HIV）和乙型肝炎病毒（HBV）潜在抗病毒药物的合成及生物学评价
J Med Chem. 1994 Mar 18;37(6):798-803. doi: 10.1021/jm00032a013.
5
Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro.2',3'-双脱氧胞苷的β-L对映体及其5-氟衍生物的体外抗人免疫缺陷病毒活性
Antimicrob Agents Chemother. 1994 Jun;38(6):1292-7. doi: 10.1128/AAC.38.6.1292.
6
Evaluation of the potent anti-hepatitis B virus agent (-) cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in a novel in vivo model.在一种新型体内模型中对强效抗乙肝病毒药物（-）顺式-5-氟-1-[2-（羟甲基）-1,3-氧硫杂环戊烷-5-基]胞嘧啶的评估。
Antimicrob Agents Chemother. 1994 Mar;38(3):616-9. doi: 10.1128/AAC.38.3.616.
7
Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.P3HR-1伯基特淋巴瘤细胞系中的免疫荧光和疱疹病毒样颗粒。
J Virol. 1967 Oct;1(5):1045-51. doi: 10.1128/JVI.1.5.1045-1051.1967.
8
Nucleosides. 136. Synthesis and antiviral effects of several 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-alkyluracils. Some structure-activity relationships.核苷。136. 几种1-(2-脱氧-2-氟-β-D-阿拉伯呋喃糖基)-5-烷基尿嘧啶的合成及抗病毒作用。一些构效关系。
J Med Chem. 1986 Jan;29(1):151-4. doi: 10.1021/jm00151a025.
9
Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions.
J Virol. 1988 Aug;62(8):2836-44. doi: 10.1128/JVI.62.8.2836-2844.1988.
10
Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil.2'-氟-5-乙基-1-β-D-阿拉伯呋喃糖基尿嘧啶的合成及生物学效应
Antimicrob Agents Chemother. 1987 Sep;31(9):1355-8. doi: 10.1128/AAC.31.9.1355.
Zotero 插件